Related Experiment Video
Updated: Aug 10, 2026

Using the Threat Probability Task to Assess Anxiety and Fear During Uncertain and Certain Threat
Published on: September 12, 2014
Fluoxetine-induced anxiety and nervousness
Małgorzata Zienowicz1, Aleksandra Wisłowska-Stanek, Małgorzata Lehner
1Department of Experimental and Clinical Pharmacology, Medical University, Krakowskie Przedmieście 26/28, PL 00-927 Warszawa, Poland. gzienow@yahoo.it
This study developed a new rat model for antidepressant side effects. Fluoxetine combined with pentetrazole (PTZ) induced anxiety-like behavior, modeling early treatment dysphoria.
Area of Science:
- Neuroscience
- Pharmacology
- Behavioral Science
Background:
- Selective serotonin reuptake inhibitors (SSRIs) like fluoxetine can cause anxiety during initial treatment.
- Understanding the neurobiological mechanisms of these side effects is crucial for improving antidepressant therapy.
Purpose of the Study:
- To develop and validate a novel animal model for fluoxetine-induced anxiety.
- To investigate the interaction between fluoxetine and pentetrazole (PTZ) in a rat model of neophobia.
Main Methods:
- Rats were treated with fluoxetine alone or in combination with a subthreshold dose of PTZ.
- Behavioral responses were assessed using the open field test to measure neophobia and exploratory behavior.
- Pharmacokinetic analysis was performed to determine brain concentrations of PTZ.
Main Results:
- Fluoxetine (5 and 10 mg/kg) did not alter motor or exploratory behavior in rats.
- Co-administration of fluoxetine (10 mg/kg) and PTZ (10 mg/kg) significantly inhibited exploratory behavior.
- No changes in brain PTZ concentrations were observed in fluoxetine-pretreated animals.
Conclusions:
- The study presents a new animal model that mimics the dysphoric-like effects of antidepressants during early treatment phases.
- The findings suggest that fluoxetine's anxiogenic effects may involve 5-HT2C receptor stimulation in the context of PTZ-induced emotional arousal.
- This model can be used to study the central mechanisms underlying antidepressant-induced anxiety.
Related Concept Videos
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Anxiolytic Drugs: Benzodiazepines and Buspirone
Anxiety: Overview
Individuals with anxiety often experience a range of physical and emotional symptoms, including sweating, trembling, tachycardia, and disturbances in sleep patterns. These symptoms vary in intensity and frequency but are generally disruptive and distressing.
Anxiolytic Drugs: Overview
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic circuitry.
Generalized Anxiety Disorder
Antidepressant Drugs: Overview